Soleno Therapeutics Income Statement (2013-2019) | SLNO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019
Revenue & cost
Revenue -0.57M-0.31M-0.39M-0.67M-0.75M-2.32M0.02M0.10M0.25M0.24M0.45M0.00M0.33M0.28M0.27M0.00M
Cost of Revenue 0.08M0.16M0.26M0.51M0.47M0.50M0.54M0.17M0.40M0.22M0.03M0.04M
Gross Profit 0.00M0.07M0.19M-0.02M-0.01M-0.05M-0.07M0.06M0.06M-0.04M
Operating items
Research & Development 0.74M0.36M0.37M0.55M0.72M0.61M0.88M1.18M1.19M1.28M1.77M0.66M0.71M0.29M0.33M0.77M0.95M1.02M
Selling, General & Administrative 0.25M0.20M0.31M0.75M0.52M1.08M1.29M1.43M1.71M1.71M1.94M1.42M1.26M1.54M1.02M2.19M1.69M1.68M
Other Operating Expenses 0.01M0.08M0.16M0.26M0.51M0.47M0.50M-0.09M0.17M251.00-0.00M0.01M0.00M
Operating Expenses 0.99M0.56M0.68M1.31M1.32M1.85M2.43M3.12M3.37M3.49M4.25M2.25M1.97M1.83M1.37M2.97M2.63M5.20M
Operating Income -0.99M-0.56M-0.68M-1.31M-1.32M-1.85M-2.43M-3.04M-3.18M-3.51M-4.26M-2.29M-1.97M-1.83M-1.37M-2.97M-2.63M-5.20M
EBIT -0.99M-0.56M-0.68M-1.31M-1.32M-1.85M-2.43M-3.04M-3.18M-3.51M-4.26M-2.29M-1.97M-1.83M-1.37M-2.97M-2.63M-5.20M
Non-operating items
Interest & Investment Income 772.0085.000.00M0.00M0.00M
Other Non Operating Income -0.03M-0.10M-0.01M-1.49M-1.07M-1.88M-9.22M4.92M-0.11M0.66M1.07M-0.07M0.19M0.41M-0.67M-0.09M0.00M0.01M
Non Operating Income -0.03M-0.10M-0.01M-1.49M-1.07M-1.88M-9.22M4.92M-0.11M0.66M1.07M-0.07M0.19M0.41M-0.67M-0.09M0.14M-0.65M
Net income details
EBT -1.56M-0.87M-1.07M-1.98M-2.08M-4.17M-2.43M-3.04M-3.18M-3.51M-4.26M-2.29M-1.97M-1.83M-1.37M-2.96M-2.63M-5.20M
Profit After Tax -1.59M-0.97M-0.83M-2.79M-2.39M-7.22M-11.65M1.88M-3.29M-2.84M-3.19M-3.51M-2.75M-2.61M-2.89M-3.97M-3.79M-4.74M
Income from Continuing Operations -1.56M-0.87M-1.07M-1.98M-2.08M-4.17M-2.43M-3.04M-3.18M-3.51M-4.26M-2.29M-1.97M-1.83M-1.37M-2.96M-2.63M-5.20M
Consolidated Net Income -1.56M-0.87M-1.07M-1.98M-2.08M-4.17M-2.43M-3.04M-3.18M-3.51M-4.26M-1.22M-0.97M-1.19M-0.84M-0.91M-1.29M-0.54M
Income towards Parent Company -1.56M-0.87M-1.07M-1.98M-2.08M-4.17M-2.43M-3.04M-3.18M-3.51M-4.26M-1.22M-0.97M-1.19M-0.84M-0.91M-1.29M-0.54M
Preferred Dividend Payments 3.65M172.00
Net Income towards Common Stockholders -1.56M-0.87M-1.07M-1.98M-2.08M-4.17M-2.43M-3.04M-3.29M-2.84M-4.26M-1.22M-6.40M-2.61M-0.84M-0.91M-1.29M-0.54M
Additional items
EPS (Basic) -2.97-1.82-1.56-5.21-4.470.82-1.670.25-0.33-0.09-220.00-0.23-0.87-1.99-0.57-0.42-0.39-0.40
EPS (Weighted Average and Diluted) -1.56-1.60-0.21
Shares Outstanding (Weighted Average) 0.08M0.08M0.09M0.09M0.10M0.11M0.16M0.21M0.21M0.21M0.21M0.63M0.63M0.64M0.67M0.67M1.32M1.43M1.43M2.12M2.12M2.12M
Shares Outstanding (Diluted Average) 0.54M7.63M15.53M
EBITDA -0.99M-0.56M-0.68M-1.31M-1.32M-1.85M-2.43M-3.04M-3.18M-3.51M-4.26M-2.29M-1.97M-1.83M-1.37M-2.97M-2.63M-5.20M
Interest Expenses 0.57M0.31M0.39M0.67M0.75M2.32M0.00M-0.00M